Bibliographic Info
GuidelineGuidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
Year of Publication2020
Issuing InstitutionPan American Health Organization
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
Very low
Treating severe or moderately severe histoplasmosis among people living with HIV: In settings where liposomal amphotericin B is unavailable, deoxycholate amphotericin B, 0.7–1.0 mg/kg, is recommended for two weeks
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year2021
InstitutionWHO
Guideline
WHO guidelines on the management of advanced HIV disease
Year2025
InstitutionWorld Health Organization